PCSK9 and Lp(a) levels of children born after assisted reproduction technologies
- 44 Downloads
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and lipoprotein (a) (Lp[a]) levels are associated with cardiovascular risk. To investigate PCSK9 and Lp(a) levels of children born after assisted reproduction technologies (ART) compared with naturally conceived (NC) controls.
In this exposure-matched cohort study, 73 racial-, sex-, and age-matched children (mean age 98 ± 35 months) of ART (intracytoplasmic sperm injection [ICSI] n = 33, classic in vitro fertilization [IVF] n = 40) and 73 NC children were assessed. Blood lipid profile, including PCSK9 and Lp(a) levels, was measured. Children were grouped according to age (< 8 years, 8–10 years, ≥ 10 years).
In the overall population, PCSK9 levels were related to total cholesterol, low-density lipoprotein, and systolic blood pressure, while Lp(a) levels were related to age, apolipoprotein-B, birth weight, height, waist-to-hip ratio, insulin resistance, insulin, and high-sensitivity C-reactive protein. No significant differences were observed regarding lipid biomarkers between ART and NC children. However, a significant interaction was found between age groups and conception method (p < 0.001) showing that PCSK9 levels increase with age in ART children, while they decline with age in NC offspring. IVF children showed higher levels of adjusted mean Lp(a) than ICSI (13.5 vs. 6.8 mg/dl, p = 0.010) and NC children (12.3 vs. 8.3 mg/dl, p = 0.048).
We show that PCSK9 levels increase with age in ART children, indicating a gradual deterioration of lipidemic profile that could lead to increased cardiovascular risk. Moreover, our results indicate that ART method may be of importance given that classic IVF is associated with higher levels of Lp(a).
KeywordsPCSK9 In vitro fertilization Assisted reproduction technologies Lipoprotein (a) Cardiovascular risk Age
Compliance with ethical standards
All children were included only after informed written consent was obtained from their parents or guardians. The study protocol was approved by the Institutional Research Ethics Committee and the Ethics Committee of the “Aghia Sophia” Children’s Hospital. The procedures followed were according to institutional guidelines and the Declaration of Helsinki.
Conflict of interest
The authors declare that they have no conflict interest.
- 4.Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papastamataki M, Papassotiriou I, et al. Absence of insulin resistance and low-grade inflammation despite early metabolic syndrome manifestations in children born after in vitro fertilization. Fertil Steril. 2010;94(5):1693–9.CrossRefGoogle Scholar
- 13.Wang XL, Wang J. Lipoprotein (a) in children and adolescence. Pediatr Endocrinol Rev. 2003;1(2):109–19.Google Scholar
- 14.Kwiterovich PO Jr, Virgil DG, Garrett ES, Otvos J, Driggers R, Blakemore K, et al. Lipoprotein heterogeneity at birth: influence of gestational age and race on lipoprotein subclasses and Lp (a) lipoprotein. Ethn Dis. 2004 Summer;14(3):351–9.Google Scholar
- 16.Kosteria I, Tsangaris GT, Gkourogianni A, Anagnostopoulos A, Papadopoulou A, Papassotiriou I, et al. Proteomics of children born after intracytoplasmic sperm injection reveal indices of an adverse cardiometabolic profile. J Endocr Soc. 2017;1(4):288–301.Google Scholar
- 26.Zlatohlávek L, Zídková K, Vrablík M, Haas T, Prusíková M, Svobodová H, et al. Lipoprotein(a) and its position among other risk factors of atherosclerosis. Physiol Res. 2008;57(5):777–83.Google Scholar